---
title: "Solara Active Pharma Sciences Ltd (SOLARA) — Share Price, Financials & Analysis"
symbol: "SOLARA"
company: "Solara Active Pharma Sciences Ltd"
canonical: "https://tapetide.com/stocks/SOLARA"
isin: "INE624Z01016"
nse_symbol: "SOLARA"
bse_code: "541540"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 3370.84
generated_at: "2026-09-13T18:46:41.837Z"
---

# Solara Active Pharma Sciences Ltd (SOLARA)

Canonical page: https://tapetide.com/stocks/SOLARA

## Company

- **NSE Symbol:** SOLARA
- **BSE Code:** 541540
- **ISIN:** INE624Z01016
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2018-06-27
- **CEO:** Mr. Sandeep Shashikantha Rao M.Sc., PGDM
- **Employees:** 1775
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** solara.co.in

## About

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]
It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.[2]

## Latest Price

- **Price:** ₹749.15
- **Change:** +41.9 (+5.92%)
- **Open:** ₹707.2
- **Day High:** ₹759.55
- **Day Low:** ₹697.4
- **Previous Close:** ₹707.25
- **Volume:** 1159874
- **As Of:** 2026-09-11T10:28:29+00:00

## Key Fundamentals

Observed at 2026-09-11T04:46:24.053491Z.

- **Market Cap:** ₹3370.84 Cr
- **Classification:** Microcap
- **P/E (reported):** -2081.9
- **EPS (TTM):** ₹-1.55
- **Book Value:** ₹261.38
- **Price to Book:** 2.71
- **Dividend Yield:** 0.42%
- **ROE:** -0.59%
- **ROCE:** 6.07%
- **Debt to Equity:** 0.55
- **Revenue (yearly):** ₹1375.1 Cr
- **Net Income:** ₹-7.4 Cr
- **EBITDA:** ₹192.9 Cr
- **52-Week High:** ₹749.8
- **52-Week Low:** ₹422
- **RSI (14):** 74.27

## Tapetide Score

- **Score:** 51 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Rising
- **Percentile:** 52 (of 4473 scored stocks)
- **Confidence:** 93%
- **Data coverage:** 86%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 24.1 | 9% |
| growth | 53.61 | 9% |
| momentum | 68.18 | 12% |
| ownership | 55.83 | 24% |
| quality | 38.85 | 22% |
| valuation | 75.63 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -3.27% over past five years.
- Company has a low return on equity of -12.0% over last 3 years.
- Promoters have pledged 37.1% of their holding.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -28.15% | 40.45% | 163.18% |
| ebitda margin growth | 2.37% | -15.53% | -302.16% | 80.8% |
| net income growth | 69.79% | — | 25% | -87.31% |
| revenue growth | -2.16% | 6.42% | -2% | -3% |
| roce | 2.1% | -32.25% | -117.55% | -3.58% |
| roe | 69.9% | — | -20.36% | -84.55% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 425 | 212 | 299 | 363 | 347 | 300 | 273 | 319 | 314 | 349 | 387 | 382 |
| Expenses | 388 | 374 | 290 | 322 | 286 | 243 | 228 | 262 | 279 | 312 | 330 | 320 |
| Operating Profit | 38 | -162 | 10 | 42 | 61 | 58 | 45 | 57 | 35 | 37 | 58 | 62 |
| OPM % | 9 | -76 | 3.3 | 12 | 18 | 19 | 17 | 18 | 11 | 11 | 15 | 16 |
| Other Income | -4 | -62 | -120 | 1 | 0 | 1 | 6 | 1 | 0 | -7 | 6 | 3 |
| Interest | 24 | 25 | 31 | 31 | 28 | 27 | 29 | 24 | 21 | 22 | 28 | 22 |
| Depreciation | 26 | 26 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 26 | 26 | 27 |
| Profit before tax | -17 | -275 | -167 | -13 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| Tax % | 0 | 0 | 53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -17 | -275 | -255 | -13 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| EPS in Rs | -3.58 | -57.36 | -53.2 | -3.74 | 2.22 | 2.24 | -0.58 | 2.91 | -2.79 | -4.82 | 2.65 | 3.41 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 521 | 1387 | 1322 | 1617 | 1268 | 1444 | 1289 | 1284 | 1369 | 1431 |
| Expenses | 464 | 1174 | 1062 | 1231 | 1188 | 1309 | 1384 | 1077 | 1182 | 1240 |
| Operating Profit | 57 | 213 | 260 | 386 | 81 | 134 | -95 | 206 | 187 | 192 |
| OPM % | 11 | 15 | 20 | 24 | 6 | 9 | -7 | 16 | 14 | 13 |
| Other Income | 2 | 12 | 27 | 29 | 16 | 22 | -185 | 8 | 0 | 2 |
| Interest | 25 | 82 | 78 | 84 | 75 | 90 | 105 | 115 | 95 | 92 |
| Depreciation | 34 | 83 | 94 | 109 | 112 | 111 | 103 | 99 | 100 | 103 |
| Profit before tax | 0 | 60 | 115 | 222 | -91 | -45 | -488 | 1 | -7 | -2 |
| Tax % | -70 | 1 | 0 | 0 | -36 | -50 | 16 | 0 | 0 | — |
| Net Profit | 0 | 59 | 115 | 221 | -58 | -22 | -567 | 1 | -7 | -2 |
| EPS in Rs | — | 17.3 | 32.01 | 46.22 | -12.11 | -4.62 | -118.21 | 0.15 | -2.05 | -1.55 |
| Dividend Payout % | 0 | 22 | 5 | 11 | 0 | -49 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 25 | 26 | 27 | 36 | 36 | 36 | 36 | 40 | 45 |
| Reserves | 739 | 930 | 1059 | 1553 | 1489 | 1464 | 898 | 1054 | 1208 |
| Borrowings | 633 | 538 | 722 | 621 | 1037 | 1013 | 1012 | 796 | 687 |
| Other Liabilities | 425 | 466 | 346 | 404 | 383 | 386 | 406 | 342 | 393 |
| Total Liabilities | 1821 | 1960 | 2153 | 2614 | 2945 | 2899 | 2351 | 2232 | 2333 |
| Fixed Assets | 1086 | 1218 | 1397 | 1382 | 1356 | 1364 | 1268 | 1193 | 1238 |
| CWIP | 71 | 40 | 40 | 88 | 239 | 238 | 256 | 280 | 205 |
| Investments | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 5 |
| Other Assets | 663 | 701 | 716 | 1144 | 1350 | 1295 | 825 | 757 | 886 |
| Total Assets | 1821 | 1960 | 2153 | 2614 | 2945 | 2899 | 2351 | 2232 | 2333 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 49 | 166 | 242 | 155 | -242 | 156 | 109 | 213 | 153 |
| Cash from Investing Activity | -85 | -113 | -359 | -106 | -243 | -81 | -4 | -37 | -99 |
| Cash from Financing Activity | 68 | -23 | 97 | 92 | 334 | -113 | -106 | -180 | -54 |
| Net Cash Flow | 31 | 30 | -20 | 142 | -151 | -38 | 0 | -4 | 1 |
| Free Cash Flow | 14 | 108 | -25 | -16 | -451 | 46 | 69 | 173 | 101 |
| CFO/OP | 92 | 85 | 103 | 49 | -277 | 106 | -113 | 104 | 83 |

### Ratios

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 184 | 76 | 63 | 109 | 141 | 136 | 99 | 93 | 117 |
| Inventory Days | 252 | 111 | 170 | 149 | 321 | 258 | 163 | 185 | 170 |
| Days Payable | 420 | 127 | 132 | 156 | 154 | 142 | 142 | 144 | 146 |
| Cash Conversion Cycle | 16 | 60 | 101 | 102 | 308 | 252 | 120 | 134 | 140 |
| Working Capital Days | -124 | -22 | -32 | 16 | 37 | 20 | -128 | -62 | -24 |
| ROCE % | — | 10 | 12 | 15 | 0 | 2 | -9 | 6 | 5 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 37.19% | 30.49% | 30.49% | 37.27% | 37.27% | 37.23% | 37.94% | 42.01% | 42.01% | 42% | 42% | 41.93% |
| FIIs | 17.86% | 16.62% | 15.8% | 14% | 14.25% | 14.67% | 14.63% | 14.25% | 13.58% | 11.98% | 11.59% | 11.52% |
| DIIs | 1.75% | 1.71% | 2.97% | 2.83% | 3.38% | 3.19% | 2.61% | 2.62% | 2.69% | 3.64% | 3.75% | 3.74% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 19.84% | 20.95% | 20.15% | 19.61% | 18.83% | 21.93% | 23.07% | 23.47% | 24.01% | 24.63% | 25.03% | 25.84% |
| Others | 23.36% | 30.22% | 30.59% | 26.29% | 26.28% | 22.98% | 21.74% | 17.63% | 17.7% | 17.74% | 17.63% | 16.97% |
| No. of Shareholders | 74473 | 72918 | 73912 | 78617 | 71882 | 83148 | 75791 | 74334 | 72479 | 71920 | 70400 | 70490 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 673.12 | Buy |
| EMA (10) | 680.5 | Buy |
| SMA (20) | 635.34 | Buy |
| EMA (20) | 643.37 | Buy |
| SMA (50) | 575.1 | Buy |
| EMA (50) | 595.88 | Buy |
| SMA (100) | 560.33 | Buy |
| EMA (100) | 568.75 | Buy |
| SMA (200) | 535.06 | Buy |
| EMA (200) | 552.48 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 79 | Sell |
| MACD (12,26,9) | 43.05 | Buy |
| Stochastic (14,3,3) | 80.2 | Sell |
| ADX (14) | 48.76 | Buy |
| Williams %R (14) | -6.57 | Sell |
| ATR (14) | 34.54 | High Volatility |
| ROC (12) | 21.36 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 54.2 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-28 | [Intimation In Connection With The Receipt Of Rectification Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65c35ae2-31a3-4b42-b66e-abe0b4baab6a.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=547713ae-e7fc-4052-9692-2de6f67fa0d9.pdf) |
| 2026-08-25 | [Notice Of The Ninth Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a8f60d8-795a-4308-a7d5-3a963f59f036.pdf) |
| 2026-08-25 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5ffab22-4ebf-40a7-9133-ce57c66bbeab.pdf) |
| 2026-08-25 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc58f42f-3f80-48fa-b815-429e255f8f28.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=074d6e06-188d-4a52-8d76-d2d08fd80386.pdf) |
| 2026-08-19 | [Conversion Of Partly Paid-Up Rights Equity Shares Into Fully Paid-Up Equity Shares In Relation To The Rights Issue By The Company Upon Receipt Of The Call Monies As Applicable](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5ec0d47-e005-4c92-aa59-feb30e508d8d.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb531967-4aee-4117-a42c-db873f954684.pdf) |
| 2026-08-07 | [Update With Respect To Our Intimation Dated July 23 2026 Regarding Appointment Of CIO And SMP Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68525433-d286-4bbe-bf66-c62c835f89c3.pdf) |
| 2026-07-24 | [Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=433eaff5-f329-4cd7-bcaa-73efb7181d3b.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26a9553e-e823-47fe-a303-ab79dbb908e8.pdf) |
| 2026-05-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc52f58d-0ba9-4545-a792-a9e134c4ed72.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf) |
| 2025-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf) |
| 2025-05-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf) |
| 2025-01-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b29a992d-d676-4e46-a1e4-d1623da7cd2f.pdf) |
| 2024-07-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ea196c2-01af-416f-aa85-aec959bae507.pdf) |
| 2024-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5271c7c0-9763-407d-bb53-ddc965891340.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-23 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c613b323-6018-484d-b106-1a952434ee34.pdf) |
| 2026-05-15 | [Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ae9617-fb5b-43b6-8159-23910ade2ee0.pdf) |
| 2026-02-06 | [Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf) |
| 2025-11-05 | [Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf) |
| 2025-07-25 | [Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf) |
| 2025-05-15 | [Audited Financial Results For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf) |
| 2025-01-24 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f78ede-dc89-44c8-b4a2-d7ecc8a379bf.pdf) |
| 2024-10-21 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af90b8a4-b506-40d0-b910-0c45407e4c37.pdf) |
| 2024-07-22 | [Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7310d508-be51-4fc7-9413-2425c6822806.pdf) |
| 2024-07-22 | [Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc7b7e11-3628-4a24-b267-9c82aded4f0e.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90cbd9dd-c288-486c-ab01-d34b696e6083.pdf) |
| 2026-05-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4bfb893-b924-4d43-b37b-5a6ae164edea.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf) |
| 2025-11-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf) |
| 2024-10-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e806b6-1e0a-4f1f-bb94-5789ac2d4bb6.pdf) |
| 2024-07-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aad8b0a7-e412-4454-8363-1ad5e184be3d.pdf) |
| 2024-05-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554bed00-d888-4035-a012-557700f22602.pdf) |
| 2024-02-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1a5b4f7-4d77-49c9-9fc4-33f5d4df690a.pdf) |
| 2023-11-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea4bbc9e-f695-4dce-bc8a-2389d1d8c9f4.pdf) |
| 2023-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d8a2ef3-2829-4680-bebf-b1b45f532b36.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b29a992d-d676-4e46-a1e4-d1623da7cd2f.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c80c36b5-5724-46ea-af3b-9b63582e165c.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b75ef5e-68ef-4eed-b743-ff697809dcf7.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0933b48-babc-4e7b-83a2-aeeb447275e3.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc52f58d-0ba9-4545-a792-a9e134c4ed72.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dc52f58d-0ba9-4545-a792-a9e134c4ed72.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fdab947e-35c8-4ae3-aec9-7835df11c109.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0996d757-2036-48b8-ba9b-d8a26cdf0c3c.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f6653f98-4599-4eeb-ac08-fa90a4604dd5.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5271c7c0-9763-407d-bb53-ddc965891340.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Meeting on Mar 24, 2026 to consider second and final call; fix record date for rights issue. | [Board Meeting Intimation for Prior Intimation Of Meeting Of Rights Issue Committee 9h - Meeting on Mar 24, 2026 to consider second and final call; fix record date for rights issue.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/87630bbe-4829-4d4a-98d0-d316d38d090e.pdf) |
| 9 Apr - Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0676ee62-888b-436b-89e0-5a4dc6bf6ecb.pdf) |
| 8h - Received Rs.161.92 Cr tax demand for AY2019-20 from DCIT Thane; company to appeal. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 8h - Received Rs.161.92 Cr tax demand for AY2019-20 from DCIT Thane; company to appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e0715c9f-a827-4dbe-bfc6-6294b1927e13.pdf) |
| 8 May - Board meets May 15, 2026 to approve audited Q4 and FY2026 standalone and consolidated results. | [Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (LODR), Regulations, 2015 ('Listing Regulations') 8 May - Board meets May 15, 2026 to approve audited Q4 and FY2026 standalone and consolidated results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f090d519-1f2f-4bd5-9662-987c1e627d01.pdf) |
| 8 Apr - Solara Active Pharma Sciences Limited has informed about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Apr - Solara Active Pharma Sciences Limited has informed about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa8a36e5-8fa4-47ba-8c89-501c3dc38fac.pdf) |
| 7 Apr - Solara issued second and final call of ₹112.50 per partly paid share; payment from Apr 23 to May 7, 2026. | [Intimation Regarding Dispatch Of The Second And Final Call Money Notice Of The Rights Equity Shares. 7 Apr - Solara issued second and final call of ₹112.50 per partly paid share; payment from Apr 23 to May 7, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/021358df-c52a-40b5-b276-6ccff963229a.pdf) |
| 4 Mar - Voluntary deregistration of non-operating Brazilian subsidiary effective July 30, 2025; nil turnover and net worth for FY2025. | [Intimation Regarding The Closure Of Wholly Owned Subsidiary Of The Company In Brazil. 4 Mar - Voluntary deregistration of non-operating Brazilian subsidiary effective July 30, 2025; nil turnover and net worth for FY2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce8f019f-6ebf-450b-980d-8b7570b3ee65.pdf) |
| 4 Mar - Received Rs93,71,512.50 for 71,402 rights shares; converted to Rs7 paid-up; paid-up capital Rs44,51,39,030.50. | [Receipt Of Call Money Pursuant To The Second Reminder Notice Issued For Payment Of First Call Money On Rights Shares 4 Mar - Received Rs93,71,512.50 for 71,402 rights shares; converted to Rs7 paid-up; paid-up capital Rs44,51,39,030.50.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/881cd28d-c598-4a2a-9c25-920456e05322.pdf) |
| 28 Apr - US FDA closed Puducherry facility inspection on Apr 24, 2026 with VAI classification. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr - US FDA closed Puducherry facility inspection on Apr 24, 2026 with VAI classification.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c5441da-8d5e-405a-915b-b67dde427e5b.pdf) |
| 28 Apr - US FDA closed Puducherry facility inspection on Apr 24, 2026 with VAI classification. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr - US FDA closed Puducherry facility inspection on Apr 24, 2026 with VAI classification.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2c5441da-8d5e-405a-915b-b67dde427e5b.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/570e7d90-62b4-4036-87a2-8db374479e32.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7abf6005-18d0-4d44-9508-cabd6bc3409e.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0bf88836-1db5-41e9-bfc4-0e7ef5693935.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/541540/74011541540.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2022-05-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=482d92d7-1b2d-4f9e-816f-9977b5325375.pdf) |
| 2021-11-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cc3f300-b79a-486c-8718-f1c3dfbd3b6c.pdf) |
| 2021-11-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f95e76c-a792-4839-a062-c4a041ca6ca6.pdf) |
| 2021-07-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=497a94be-eb48-46c6-8010-ed168e82f94f.pdf) |
| 2021-05-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2632d123-0d07-4615-87cb-231e07b011cd.pdf) |
| 2021-05-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08059b4e-4e90-4672-ab0f-cc93bb06d094.pdf) |
| 2021-04-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7f1b33b-55e2-4aaf-924c-9393fd0a7cd5.pdf) |
| 2021-04-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc4b8d50-2534-4280-b790-322869dd102d.pdf) |
| 2021-04-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=838bc498-80e4-429c-a274-54d73bd5b6d6.pdf) |
| 2021-04-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f9761c-956b-497f-93b2-4120457e9a6f.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:46:41.837Z.